Neogen's Q3 Earnings Miss Street Expectations On Higher Raw Material, Freight Expenses

Loading...
Loading...

Neogen Corporation's NEOG Q3 FY22 sales increased 9.9% Y/Y to $128.2 million, missing the consensus of $129.99 million.

  • Food Safety segment revenue reached $62.7 million, +7% (+4% on an organic basis). 
  • Sales of the new AccuPoint Advanced NG handheld sanitation monitoring system drove a 16% increase in general sanitation product line sales. 
  • The Soleris rapid general microbial testing product line recorded a 10% increase in equipment sales, and Listeria Right Now 60-minute test system sales recorded a rise of 13%.
  • Related: 3M Agrees To Combine Food Safety Business With Neogen.
  • Animal Safety segment sales increased 12% Y/Y to $65.5 million (+9% organically). 
  • The growth was driven by solid sales of veterinary instruments, up 36% on market share gains and private label business. 
  • Animal care products increased by 12%, with vitamin injectables and antibiotics growth.
  • Gross margins were 44.8%, down from 46.1% a year ago. Ongoing supply chain issues and the current inflationary environment continued to impact raw material costs and freight expenses adversely.
  • Additionally, a product mix shift toward Animal Safety products, which generally have lower gross margins, negatively impacted gross margins for the period.
  • The Company reported adjusted EPS of $0.13 missing the consensus of $0.15.
  • Price Action: NEOG shares are down 8.60% at $30.84 during the market session on the last check Thursday.
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Date
ticker
name
Actual EPS
EPS Surprise
Actual Rev
Rev Surprise
Posted In: EarningsNewsHealth CareMoversTrading IdeasGeneralBriefs
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...